|
Volumn 26, Issue 3 SUPPL., 1997, Pages
|
Therapy of hepatitis C: Interferon alfa-2a trials
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ALPHAN1 INTERFERON;
AMINOTRANSFERASE;
HEPATITIS C ANTIBODY;
INTERFERON ANTIBODY;
NEUTRALIZING ANTIBODY;
PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;
RECOMBINANT ALPHA2A INTERFERON;
RIBAVIRIN;
URSODEOXYCHOLIC ACID;
VIRUS RNA;
ADULT;
AGED;
CHRONIC ACTIVE HEPATITIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
LIVER BIOPSY;
LIVER CIRRHOSIS;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
|
EID: 0030886319
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510260716 Document Type: Conference Paper |
Times cited : (50)
|
References (27)
|